Literature DB >> 22151725

Interactions between tumor cells and microenvironment in breast cancer: a new opportunity for targeted therapy.

Shreya Mitra1, Katherine Stemke-Hale, Gordon B Mills, Sofie Claerhout.   

Abstract

Breast cancer remains the leading cause of morbidity and second-leading cause of death in women. Despite efforts to uncover new targeted therapies, a vast number of women die due to refractory or recurrent breast tumors. Most breast cancer studies have focused on the intrinsic characteristics of breast tumor cells, including altered growth, proliferation, and metabolism. However, emerging research suggests that the tumor microenvironment can substantially affect relapse rates and therapeutic responses. In this review, we discuss the interactions between the tumor and microenvironment in breast cancer, with regard to mutational profiles and altered metabolism that could serve as potential therapeutic targets. We also describe current technologies available to study these interactions.
© 2011 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22151725      PMCID: PMC5439106          DOI: 10.1111/j.1349-7006.2011.02183.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  76 in total

Review 1.  Does tumour dormancy offer a therapeutic target?

Authors:  Paul E Goss; Ann F Chambers
Journal:  Nat Rev Cancer       Date:  2010-11-04       Impact factor: 60.716

2.  Mammary development meets cancer genomics.

Authors:  Aleix Prat; Charles M Perou
Journal:  Nat Med       Date:  2009-08       Impact factor: 53.440

Review 3.  Gene-expression profiles, tumor microenvironment, and cancer stem cells in breast cancer: latest advances towards an integrated approach.

Authors:  Laura Vera-Ramirez; Pedro Sanchez-Rovira; Cesar L Ramirez-Tortosa; Jose L Quiles; M Carmen Ramirez-Tortosa; J Carlos Alvarez; Monica Fernandez-Navarro; Jose A Lorente
Journal:  Cancer Treat Rev       Date:  2010-03-17       Impact factor: 12.111

4.  Distinct epigenetic changes in the stromal cells of breast cancers.

Authors:  Min Hu; Jun Yao; Li Cai; Kurt E Bachman; Frédéric van den Brûle; Victor Velculescu; Kornelia Polyak
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

5.  Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.

Authors:  Mahvash Zakikhani; Ryan Dowling; I George Fantus; Nahum Sonenberg; Michael Pollak
Journal:  Cancer Res       Date:  2006-10-23       Impact factor: 12.701

6.  Interactions with fibroblasts are distinct in Basal-like and luminal breast cancers.

Authors:  J Terese Camp; Fathi Elloumi; Erick Roman-Perez; Jessica Rein; Delisha A Stewart; J Chuck Harrell; Charles M Perou; Melissa A Troester
Journal:  Mol Cancer Res       Date:  2010-12-03       Impact factor: 5.852

7.  Metformin induces unique biological and molecular responses in triple negative breast cancer cells.

Authors:  Bolin Liu; Zeying Fan; Susan M Edgerton; Xin-Sheng Deng; Irina N Alimova; Stuart E Lind; Ann D Thor
Journal:  Cell Cycle       Date:  2009-07-21       Impact factor: 4.534

8.  Stromal metalloproteinase-9 is essential to angiogenesis and progressive growth of orthotopic human pancreatic cancer in parabiont nude mice.

Authors:  Toru Nakamura; Toshio Kuwai; Jang-Seong Kim; Dominic Fan; Sun-Jin Kim; Isaiah J Fidler
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

9.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

10.  Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer.

Authors:  Anne Planche; Marina Bacac; Paolo Provero; Carlo Fusco; Mauro Delorenzi; Jean-Christophe Stehle; Ivan Stamenkovic
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

View more
  7 in total

Review 1.  Metabolic implication of tumor:stroma crosstalk in breast cancer.

Authors:  Andrea Morandi; Paola Chiarugi
Journal:  J Mol Med (Berl)       Date:  2014-01-24       Impact factor: 4.599

2.  High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells.

Authors:  Xi-Long Zhao; Yong Lin; Jun Jiang; Zhuo Tang; Shuai Yang; Lu Lu; Yan Liang; Xue Liu; Jiao Tan; Xu-Gang Hu; Qin Niu; Wen-Juan Fu; Ze-Xuan Yan; De-Yu Guo; Yi-Fang Ping; Ji Ming Wang; Xia Zhang; Hsiang-Fu Kung; Xiu-Wu Bian; Xiao-Hong Yao
Journal:  J Pathol       Date:  2017-09-21       Impact factor: 7.996

3.  Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft model.

Authors:  Sandra J Yokota; John G Facciponte; Raymond J Kelleher; Leonard D Shultz; Jenni L Loyall; Robert R Parsons; Kunle Odunsi; John G Frelinger; Edith M Lord; Scott A Gerber; Sathy V Balu-Iyer; Richard B Bankert
Journal:  Cancer Immun       Date:  2013-05-31

Review 4.  Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

Authors:  Nicole M Davis; Melissa Sokolosky; Kristin Stadelman; Steve L Abrams; Massimo Libra; Saverio Candido; Ferdinando Nicoletti; Jerry Polesel; Roberta Maestro; Antonino D'Assoro; Lyudmyla Drobot; Dariusz Rakus; Agnieszka Gizak; Piotr Laidler; Joanna Dulińska-Litewka; Joerg Basecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Giuseppe Montalto; Melchiorre Cervello; Timothy L Fitzgerald; Zoya Demidenko; Alberto M Martelli; Lucio Cocco; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2014-07-15

5.  Identification of Novel Multi-Omics Expression Landscapes and Meta-Analysis of Landscape-Based Competitive Endogenous RNA Networks in ALDH+ Lung Adenocarcinoma Stem Cells.

Authors:  Wei Yang; Yong Liang; Yuanyuan Zheng; Haitao Luo; Xiaofei Yang; Furong Li
Journal:  Biomed Res Int       Date:  2022-08-31       Impact factor: 3.246

6.  Stromal fibroblasts in the microenvironment of gastric carcinomas promote tumor metastasis via upregulating TAGLN expression.

Authors:  Beiqin Yu; Xuehua Chen; Jianfang Li; Ying Qu; Liping Su; Yibing Peng; Jian Huang; Jun Yan; Yingyan Yu; Qinlong Gu; Zhenggang Zhu; Bingya Liu
Journal:  BMC Cell Biol       Date:  2013-03-19       Impact factor: 4.241

7.  Evaluation of nanoparticle uptake in co-culture cancer models.

Authors:  Elisabete C Costa; Vítor M Gaspar; João G Marques; Paula Coutinho; Ilídio J Correia
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.